SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

AdaptHealth Corp. – ‘10-Q’ for 9/30/20 – ‘EXCEL’

On:  Friday, 11/6/20, at 4:32pm ET   ·   For:  9/30/20   ·   Accession #:  1558370-20-13175   ·   File #:  1-38399

Previous ‘10-Q’:  ‘10-Q’ on 8/7/20 for 6/30/20   ·   Next:  ‘10-Q’ on 5/10/21 for 3/31/21   ·   Latest:  ‘10-Q’ on 5/7/24 for 3/31/24   ·   10 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/06/20  AdaptHealth Corp.                 10-Q        9/30/20   82:10M                                    Toppan Merrill Bridge/FA

Quarterly Report   —   Form 10-Q
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   1.69M 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     26K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     26K 
 4: EX-32       Certification -- §906 - SOA'02                      HTML     24K 
11: R1          Document and Entity Information                     HTML     82K 
12: R2          Consolidated Balance Sheets                         HTML    125K 
13: R3          Consolidated Balance Sheets (Parenthetical)         HTML     42K 
14: R4          Consolidated Statements of Operations               HTML    100K 
15: R5          Consolidated Statements of Comprehensive Income     HTML     46K 
                (Loss)                                                           
16: R6          Consolidated Statements of Changes in               HTML    170K 
                Stockholders' Equity (Deficit) / Members' Equity                 
                (Deficit)                                                        
17: R7          Consolidated Statements Of Changes in               HTML     26K 
                Stockholders' Equity (Deficit) (Parenthetical)                   
18: R8          Consolidated Statements of Cash Flows               HTML    155K 
19: R9          General Information                                 HTML     47K 
20: R10         Revenue Recognition and Accounts Receivable         HTML    138K 
21: R11         Significant Transactions                            HTML    101K 
22: R12         Equipment and Other Fixed Assets                    HTML     40K 
23: R13         Goodwill and Identifiable Intangible Assets         HTML     51K 
24: R14         Fair Value of Assets and Liabilities                HTML    152K 
25: R15         Derivative Instruments and Hedging Activities       HTML     41K 
26: R16         Accounts Payable and Accrued Expenses               HTML     37K 
27: R17         Debt                                                HTML     63K 
28: R18         Stockholders' Equity                                HTML     67K 
29: R19         Earnings Per Share                                  HTML     82K 
30: R20         Leases                                              HTML     46K 
31: R21         Income Taxes                                        HTML     30K 
32: R22         Commitments and Contingencies                       HTML     26K 
33: R23         Related Party Transactions                          HTML     26K 
34: R24         Subsequent Events                                   HTML     25K 
35: R25         General Information (Policies)                      HTML     58K 
36: R26         General Information (Tables)                        HTML     28K 
37: R27         Revenue Recognition and Accounts Receivable         HTML    127K 
                (Tables)                                                         
38: R28         Significant Transactions (Tables)                   HTML     95K 
39: R29         Equipment and Other Fixed Assets (Tables)           HTML     39K 
40: R30         Goodwill and Identifiable Intangible Assets         HTML     53K 
                (Tables)                                                         
41: R31         Fair Value of Assets and Liabilities (Tables)       HTML    146K 
42: R32         Derivative Instruments and Hedging Activities       HTML     39K 
                (Tables)                                                         
43: R33         Accounts Payable and Accrued Expenses (Tables)      HTML     37K 
44: R34         Debt (Tables)                                       HTML     47K 
45: R35         Stockholders' Equity (Tables)                       HTML     46K 
46: R36         Earnings Per Share (Tables)                         HTML     24K 
47: R37         Leases (Tables)                                     HTML     45K 
48: R38         General Information (Details)                       HTML     32K 
49: R39         Revenue Recognition and Accounts Receivable         HTML     80K 
                (Details)                                                        
50: R40         Significant Transactions - Consideration and        HTML    140K 
                Allocation (Details)                                             
51: R41         Significant Transactions - Pro-forma Financial      HTML     32K 
                Information and Results of Business Acquired                     
                (Details)                                                        
52: R42         Significant Transactions - Business Combination     HTML     36K 
                (Details)                                                        
53: R43         Equipment and Other Fixed Assets (Details)          HTML     37K 
54: R44         Goodwill and Identifiable Intangible Assets         HTML     30K 
                (Details)                                                        
55: R45         Goodwill and Identifiable Intangible Assets -       HTML     62K 
                Intangible Assets (Details)                                      
56: R46         Fair Value of Assets and Liabilities - Valuation    HTML     51K 
                of Financial Assets and Liabilities (Details)                    
57: R47         Fair Value - Contingent Consideration (Details)     HTML     40K 
58: R48         Fair Value of Assets and Liabilities -              HTML     29K 
                Non-financial Assets Measured on Non-recurring                   
                Basis (Details)                                                  
59: R49         Derivative Instruments and Hedging Activities -     HTML     36K 
                Financial instruments (Details)                                  
60: R50         Derivative Instruments and Hedging Activities -     HTML     26K 
                Effect on Accumulated Other Comprehensive Income                 
                (Details)                                                        
61: R51         Derivative Instruments and Hedging Activities -     HTML     27K 
                Not designated (Details)                                         
62: R52         Accounts Payable and Accrued Expenses (Details)     HTML     33K 
63: R53         Debt (Details)                                      HTML     66K 
64: R54         Debt - Long term debt (Details)                     HTML     96K 
65: R55         Debt - Notes (Details)                              HTML    114K 
66: R56         Stockholders' Equity (Details)                      HTML    140K 
67: R57         Stockholders' Equity - Equity-based compensation    HTML     44K 
                (Details)                                                        
68: R58         Stockholders' Equity - Common stock awards          HTML     34K 
                (Details)                                                        
69: R59         Stockholders' Equity - Options activity and         HTML     38K 
                assumptions (Details)                                            
70: R60         Stockholders' Equity - Restricted stock (Details)   HTML    106K 
71: R61         Stockholders' Equity - Incentive Units (Details)    HTML     34K 
72: R62         Earnings Per Share (Details)                        HTML     69K 
73: R63         Leases - Capital leases (Details)                   HTML     53K 
74: R64         Leases - Operating (Details)                        HTML     47K 
75: R65         Income Taxes (Details)                              HTML     36K 
76: R66         Commitments and Contingencies (Details)             HTML     27K 
77: R67         Related Party Transactions (Details)                HTML     35K 
78: R68         Subsequent Events - Financing and Acquisitions      HTML     37K 
                (Details)                                                        
80: XML         IDEA XML File -- Filing Summary                      XML    149K 
10: XML         XBRL Instance -- ahco-20200930x10q_htm               XML   2.46M 
79: EXCEL       IDEA Workbook of Financial Reports                  XLSX    108K 
 6: EX-101.CAL  XBRL Calculations -- ahco-20200930_cal               XML    209K 
 7: EX-101.DEF  XBRL Definitions -- ahco-20200930_def                XML    852K 
 8: EX-101.LAB  XBRL Labels -- ahco-20200930_lab                     XML   1.60M 
 9: EX-101.PRE  XBRL Presentations -- ahco-20200930_pre              XML   1.16M 
 5: EX-101.SCH  XBRL Schema -- ahco-20200930                         XSD    187K 
81: JSON        XBRL Instance as JSON Data -- MetaLinks              422±   636K 
82: ZIP         XBRL Zipped Folder -- 0001558370-20-013175-xbrl      Zip    353K 


‘EXCEL’   —   IDEA Workbook of Financial Reports


This is an IDEA Workbook.

        Download this Microsoft® Excel® .xlsx workbook


3 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/07/21  AdaptHealth Corp.                 424B5                  1:2M                                     Toppan Merrill/FA
 1/04/21  AdaptHealth Corp.                 424B5                  1:2M                                     Toppan Merrill/FA
12/18/20  AdaptHealth Corp.                 S-3                    7:948K                                   Toppan Merrill/FA


7 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

10/22/20  AdaptHealth Corp.                 8-K:1,2,9  10/16/20   11:213K                                   Toppan Merrill/FA
 8/21/20  AdaptHealth Corp.                 8-K:5,9     8/18/20   11:272K                                   Toppan Merrill/FA
 8/04/20  AdaptHealth Corp.                 8-K:1,2,9   7/29/20    3:2.2M                                   Toppan Merrill/FA
 7/02/20  AdaptHealth Corp.                 8-K:1,2,3,5 7/01/20    6:708K                                   Toppan Merrill/FA
 6/26/20  AdaptHealth Corp.                 8-K:1,3,5,9 6/24/20    5:929K                                   Toppan Merrill/FA
 3/06/20  AdaptHealth Corp.                 10-K       12/31/19  106:14M                                    Toppan Merrill Bridge/FA
11/14/19  AdaptHealth Corp.                 8-K:1,2,4,511/07/19   25:6.7M                                   Toppan Merrill/FA
Top
Filing Submission 0001558370-20-013175   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., May 15, 9:47:23.2pm ET